Eagle Boston Investment Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$1.16M Sell
33,322
-47,412
-59% -$1.53M 1.33% 27
2019
Q1
$2.37M Sell
80,734
-32,971
-29% -$934K 1.03% 38
2018
Q4
$2.92M Sell
113,705
-232,308
-67% -$8.04M 1.01% 34
2018
Q3
$12.2M Buy
346,013
+69,530
+25% +$2.77M 1.09% 38
2018
Q2
$11.3M Buy
276,483
+24,436
+10% +$985K 1.04% 43
2018
Q1
$9.88M Buy
252,047
+11,778
+5% +$432K 0.98% 45
2017
Q4
$7.84M Buy
240,269
+113,592
+90% +$3.94M 0.78% 70
2017
Q3
$6.03M Buy
126,677
+1,852
+1% +$90.3K 0.62% 80
2017
Q2
$6.16M Buy
124,825
+39,129
+46% +$1.73M 0.67% 75
2017
Q1
$3.74M Buy
85,696
+22,212
+35% +$901K 0.42% 91
2016
Q4
$2.1M Buy
+63,484
New +$2.46M 0.25% 98

Other funds holding ACHC

Eagle Boston Investment Management's ACHC Position: Q2 2019 in Review

Eagle Boston Investment Management reduced its Acadia Healthcare (ACHC) stake by 59% in Q2 2019, selling an estimated $1.53M and leaving 33,322 shares worth $1.16M. The position accounts for 1.33% of the portfolio, ranked #27.

Eagle Boston Investment Management first reported a position in ACHC in Q4 2016 and has held it in 11 quarters since. The position peaked at $12.2M in Q3 2018. 234 funds tracked by Wall St. Rank hold ACHC as of Q2 2019.

  • Eagle Boston Investment Management held 33,322 shares of Acadia Healthcare worth $1.16M as of Q2 2019.
  • Eagle Boston Investment Management sold 47,412 Acadia Healthcare shares in Q2 2019, an estimated $1.53M.
  • Acadia Healthcare made up 1.33% of Eagle Boston Investment Management's portfolio in Q2 2019, its #27 holding.
  • Eagle Boston Investment Management first reported a position in Acadia Healthcare in Q4 2016 and has held it in 11 quarters since.
  • Eagle Boston Investment Management's Acadia Healthcare position peaked at $12.2M in Q3 2018.
  • 234 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2019.

Based on Eagle Boston Investment Management's 13F filing for Q2 2019, filed 5 Aug 2019.